Browsing by author "Ting, Ru-Dee"
Sort by:
Title A-Z
-
The clinical implications of type 2 diabetic renal disease and the use of fenofibrate as a novel therapy
Ting, Ru-DeePublished 2014-05-01Diabetic renal disease is a serious complication and the FIELD study, a trial of the PPAR agonist fenofibrate in type 2 diabetes, provides an opportunity to address it. We found that eGFR and urinary albumin to creatinine ...USyd AccessThesis -
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study
Davis, Timothy ME; Ting, Ru-Dee; Best, James D; Donoghoe, Mark; Drury, Paul L; Sullivan, David R; Jenkins, Alicia J; O'Connell, Rachel L; Whiting, Malcolm; Glasziou, Paul; Simes, R John; Kesaniemi, Y Antero; Gebski, Val; Scott, Russell; Keech, Anthony CPublished 2011-02-01Abstract Aims/hypothesis Fenofibrate caused an acute, sustained plasma creatinine increase in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) and Action to Control Cardiovascular Risk in Diabetes ...Open AccessPost-print -
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
Drury, Paul L; Ting, Ru-Dee; Zannino, Diana; Ehnholm, Christian; Flack, Jeff; Whiting, Malcolm; Fassett, Robert; Ansquer, Jean-Claud; Dixon, Paul; Davis, Timothy ME; Pardy, Christopher; Colman, Peter; Keech, AnthonyPublished 2011-01-01Background We investigated effects of renal function and albuminuria on cardiovascular outcomes in 9795 low-risk patients with diabetes in the Fenofibrate Intervention and Event Lowering in Diabetes study. Methods Baseline ...Open AccessArticle
Sort by:
Title A-Z